According to a report by Singapore's "Lianhe Zaobao," Dr. Larsson and Dr. Volker from the Karolinska Institute in Sweden jointly published a report in the American Journal of Gastroenterology, pointing out that the medical community has accumulated a great deal of research data over the past 20 years on the potential benefits of coffee for liver function and liver diseases; several studies have found an inverse relationship between coffee consumption and liver enzyme levels, and the levels of these enzymes are in turn related to the risk of developing chronic liver disease and cirrhosis.
Therefore, the researchers conducted a large-scale review of published epidemiological studies to determine the relationship between coffee consumption and the risk of developing liver cancer. They performed a meta-analysis of 11 research studies, involving a total of 2,260 liver cancer patients and 239,146 healthy individuals used for comparison.
The researchers found that all studies showed an inverse relationship between coffee consumption and the risk of liver cancer, and this relationship was particularly significant in six of the studies.
Larsson and Volker pointed out that coffee contains a large amount of antioxidants such as chlorogenic acid, which can combat oxidative stress and prevent the formation of carcinogens. Furthermore, experiments conducted on animals have also clearly shown that coffee and chlorogenic acid have an inhibitory effect on liver cancer.